Am. Gardier et al., 8-OH-DPAT ATTENUATES THE DEXFENFLURAMINE-INDUCED INCREASE IN EXTRACELLULAR SEROTONIN - AN IN-VIVO DIALYSIS STUDY, European journal of pharmacology, 265(1-2), 1994, pp. 107-110
Rats with frontocortical microdialysis probes were treated with dexfen
fluramine or dexfenfluramine with 8-hydroxy-2-(di-n-propylamino)tetral
in (8-OH-DPAT) pretreatement. Dexfenfluramine (10 mg/kg i.p.) increase
d extracellular serotonin (5-hydroxytryptamine, 5-HT) (calculated area
under the curve (AUC) for the 0 to 105-min period after dexfenflurami
ne treatment = 8.22 +/- 2.66 pmol 5-HT). Systemic (0.025 mg/kg i.p.) o
r local (0.01 mu M into the dorsal raphe nucleus) 8-OH-DPAT pretreatem
ent decreased the dexfenfluramine response (AUC: 1.03 +/- 0.07 and 0.4
4 +/- 0.04 pmol 5-HT, respectively). This result might be explained by
the decrease in 5-HT neuronal discharge caused by somatodendritic 5-H
T1A autoreceptor activation, and suggests that the 5-HT releasing effe
ct of dexfenfluramine in vivo depends on nerve terminal depolarization
.